The human interleukin-29 ELISA test (IL-29) quantifies human LY-29 in serum, plasma, buffered solution or human cell culture medium.The assay will recognize only natural human LY-29 and human culture media.The assay will...
The human ELISA test for human interleukin-29 (IL-29) quantifies human LIL-29 in serum, plasma, The assay will recognize only the natural and recombinant human L-IL-29.The L-ELISA (immuno-enzymatic test) solid phase sandwich for human L-29 is designed to measure the amount of the target bound between a pair of matched antibodies.A target specific antibody was pre-selected in the wells d The samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture).The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal.The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.Strict validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, The accuracy and consistency of batch to batch.See the product manual for more information on validation.
L的IL-29 is a protein in the helical cytokine family and is an interferon type III that shares many functions with the interferon type I family. The IL- gene is found on chromosome 19 in humans. It is also known as IFN-lambda1 and is very similar in terms of amino acid sequence to IL-28, the other interferon type III. L- does not bind the IFN-alpha/beta receptor, but rather the signals via a receiver consisting of IL-28R1 and IL-10R2 subunits. Initial receptor characterizations showed that it has a ubiquitous tissue distribution and is expressed on most non-haematopoietic cells.
The native d的IL-29 generation is performed by monocytes and dendritic cells in response to viral infection and stimulation by Toll receptor ligands. The host's defences against microbes play an important role in the IL-29 and its gene is highly regulated in virus-infected cells. The IL- has significant antiviral activity and immunoregulatory properties and appears to inhibit T 2 (Th2) luteiliary responses to inhibition of the production of IL-13, compared to IL-4 or IL-5. Antiviral activities of the IL-29 include regulation of MHC class I expression on the cell surface and expression of PKR. The ligand/receptor complex appears to indicate Jak-STAT.
Sensitivity
Sensitivity of the dosage: 2.0 pg/ml.
Measurement range
Dose range: 15.6-1.000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of intra-dose variation 7.6%, inter-dose 7.1%.
Technical specifications
| General |
| Brand | Invitrogen |
| Specifications |
| Accession number | Q8IU54 |
| Dose range | 15.6-1.000 pg/ml |
| Sensitivity of the dosage | 2.0 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 282618 |
| Gene symbol(s) | IL-29,IL29 |
| Coefficient of inter-dose variation | 7.1% |
| Coefficient of intra-dose variation | 7.6% |
| Contents of kits | 96-well pre-coated plate, Stalion, Sample thinner, Dose buffer concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive Plate Covers, Adhesive Plate Covers |
| Marker or dye | HRP |
| Regulatory status | RUO |
| Synonym | IFNL1, interleukin 29 |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
A question or a specific configuration?
Contact us for a quote.